TITLE:
      Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment
SUMMARY:
      Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension,
      who do not tolerate ACE inhibitoR treatment
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Patients over 18 years of age

          -  Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)

          -  Patients, who do not tolerate ACE inhibitors (must be documented in the official
             ambulant documentation)

        Inclusion criteria for the control arm (treated by ACEi):

          -  Patients over 18 years of age

          -  Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)

          -  Patients, who tolerate ACEi treatment

        Exclusion Criteria:

          -  Cholestasis, severe hepatic insufficiency

          -  Allergy to telmisartan

          -  Gravidity or lactation

        Exclusion criteria for the arm of patient treated by ACEi:

          -  Cholestasis, severe hepatic insufficiency

          -  Allergy to ACEi

          -  Gravidity or lactation
